Sagimet Biosciences Inc Series A (SGMT) Stock Price, Quote & News

Company Profile

Sagimet Biosciences Inc., a clinical-stage biopharmaceutical company, develops novel therapeutics called fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional metabolic pathways in the United States. The company's lead drug candidate is Denifanstat, an oral, once-daily pill and selective FASN inhibitor for the treatment of metabolic dysfunction-associated steatohepatitis. It also develops TVB-3567, a FASN inhibitor for the treatment of acne; and other...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 561 8600

Website: www.sagimet.com

Address:

155 Bovet Road, Suite 303, San Mateo, United States

galaxySky Feb. 4 at 6:49 PM

$SGMT tech (ai) and novo nordisk is causing some fear hence today’s drop. goog earnings this afternoon may articficially deflate the entire market. it seems that is what is predicted anyhow given amd. sgmt has value regardless of the noise. good chance to buy if anything.

0 · Reply

Jiggitus23 Feb. 4 at 5:24 PM

$SGMT just added 30k shares

1 · Reply

Biostock Feb. 4 at 5:11 PM

$SGMT 500% upside. $37 Target by Clear Street $SPY $QQQ $XBI $LABU

1 · Reply

galaxySky Feb. 4 at 3:21 PM

$SGMT Given the pop to 7.2 yesterday on great news, this is just giving us all more of an opportunity to buy in.

0 · Reply

Biostock Feb. 4 at 3:51 AM

$SGMT $122 million milestone payment for completed successful P3 Acne trial and royalties for China after approval. $SPY $QQQ

1 · Reply

loveusa1988 Feb. 4 at 12:52 AM

$SGMT Made close to 4 K here thanks to @jacksparo email group

0 · Reply

Biostock Feb. 3 at 10:47 PM

$SGMT 27+ Coming. Barclays caught in short with their short down? $SPY $QQQ

0 · Reply

BioRich Feb. 3 at 7:45 PM

$ALT Love Guggenheim tying $SGMT to $MDGL. I love that combination. #27Dresses

2 · Reply

Biostock Feb. 3 at 7:45 PM

$SGMT $27 Let's go $SPY $QQQ

0 · Reply

galaxySky Feb. 3 at 6:35 PM

$SGMT The gap and sell off is interesting especially with the volume around both scenarios. They may very well push this down to the 5s again. But now the cat is out of the bag. We all know it’s a steal down there. They’d do well to have this hover around 10 again before the next leg up on any of the future catalysts.

1 · Reply